AB: This a good coverage on healthcare in the US as compared to other countries. It is long. It also has many charts and graphs rather than words. This is why I posted this at Angry Bear. It is easy to grasp the implications. U.S. Health Care from a Global Perspective, 2022, Commonwealth Fund, Munira Z. Gunja, Evan D. Gumas, Reginald D. Williams II Introduction In the previous edition of U.S. Health Care from a Global Perspective, we...
Read More »Healthcare in the US from a Global Perspective. Are we that good?
AB: This a good coverage on healthcare in the US as compared to other countries. It is long. It also has many charts and graphs rather than words. This is why I posted this at Angry Bear. It is easy to grasp the implications. U.S. Health Care from a Global Perspective, 2022, Commonwealth Fund, Munira Z. Gunja, Evan D. Gumas, Reginald D. Williams II Introduction In the previous edition of U.S. Health Care from a Global Perspective, we...
Read More »Yellow rain and the natural origin of a “bioweapon”
A recent discussion thread concerning the “lab leak” hypothesis for the origin of SARS-CoV-2 reminded me of another conspiracy theory involving claims of a bioweapon that also probably had a natural origin.The US government claimed that the Soviet Union was using trichothecene mycotoxins as biological weapons in Southeast Asia in the mid-1970s. In support of this, they pointed to the finding of mycotoxin on leaves and in the blood of people who...
Read More »Yellow rain and the natural origin of a “bioweapon”
A recent discussion thread concerning the “lab leak” hypothesis for the origin of SARS-CoV-2 reminded me of another conspiracy theory involving claims of a bioweapon that also probably had a natural origin.The US government claimed that the Soviet Union was using trichothecene mycotoxins as biological weapons in Southeast Asia in the mid-1970s. In support of this, they pointed to the finding of mycotoxin on leaves and in the blood of people who...
Read More »Akorn Pharma calls it quits and closes all US sites
Earlier this year, one company’s closing is adding to national pharmaceutical shortages and capacity in its bankruptcy. The closing can be construed as more than just allowing a laissez-faire economic policy. There are greater healthcare implications for the US. The nation can rescue banks, companies such as AIG, and those gambling with CDS, countering naked CDS, tranched CDOs threatening the national economy. It fails to see the threat of the...
Read More »SARS-CoV-2 was probably not released from a research lab
I’m a molecular biologist who also has an undergrad degree in microbiology. Those facts and the additional facts that (a) I was in the Moderna phase III trial and (b) my medical school is one of ten NIH designated vaccine testing and evaluation units made me an avid student of the unfolding COVID-19 story. Given everything we know over centuries of experience, the null hypothesis is that any pandemic has a natural origin. But since the COVID-19...
Read More »Five Reasons for Congress to Protect the 340B Program
This is one article I have found which openly supports the 340B program and establishes the reasons for a need of the program. Hospitals located in areas of low income citizens and uninsured patients are more likely to make use of this program than those in more affluent areas. Efforts disparaging this program because of bad players would weigh heavily amongst those institutions located in poorer areas providing care to their clients of need and the...
Read More »A little-known federal contractor is a big player in privatizing government services
We are again discussing people on Medicaid who may not know they have to reenroll. The largest unknowing segment of that population are those over 65 years of age. This is a combination of several different articles on the Medicaid Disenrollment occurring today. Private business again taking advantage of the lack of knowledge of people and the situation. The Company Salivating Over The Medicaid Disaster (levernews.com), Matthew Cunningham-Cook...
Read More »Conflicts of Interest on Company Prescription Plans
This is interesting. Companies, large companies, and public institutions hire consulting firms to research drug coverage for their employees. This is what companies and institutions do, get the experts to come in, use their expertise and knowledge of the process or the market, to get the best efficiencies or deals at lower costs. The way STAT reports it, the consultants are playing both sides. The consultants sign on with the companies for a fee. In...
Read More »Conflicts of Interest on Company Prescription Plans
This is interesting. Companies, large companies, and public institutions hire consulting firms to research drug coverage for their employees. This is what companies and institutions do, get the experts to come in, use their expertise and knowledge of the process or the market, to get the best efficiencies or deals at lower costs. The way STAT reports it, the consultants are playing both sides. The consultants sign on with the companies for a fee. In...
Read More »